Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Vista Pharmaceuticals Ltd.

Vista Pharma

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
30 06 2021 Audited Results
14 08 2021 Quarterly Results & A.G.M.
13 11 2021 Quarterly Results
14 02 2022 Quarterly Results
30 05 2022 Quarterly Results
13 08 2022 Quarterly Results
08 09 2022 Issue Of Warrants
14 11 2022 Quarterly Results
13 02 2023 Quarterly Results
30 05 2023 Audited Results
12 08 2023 Quarterly Results
06 09 2023 A.G.M. & Preferential Issue of shares
10 11 2023 Quarterly Results
10 02 2024 Quarterly Results
13 11 2024 Quarterly Results
12 02 2025 Quarterly Results
19 02 2025 Preferential Issue of shares & Inter alia, to consider and approve :- 1. The proposal of raising of funds by way of issue of equity or convertible warrants on preferential basis, subject to the receipt of necessary approvals/permissions. 2. To approve the Notice of the Extraordinary General Meeting for the approval of raising of funds. 3. Any other business with the permission of the Chair.
30 05 2025 Audited Results
13 08 2025 Quarterly Results
13 11 2025 Quarterly Results
13 02 2026 Quarterly Results (Revised)

News

03-FEB-2026

Vista Pharmaceuticals enters into joint venture partnership with Pleiades Therapeutics

The collaboration is expected to enhance operational capabilities, expand market reach

04:51 PM
Enrich money logo